A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Glavni autor: | Sorno, Rubina Haque |
---|---|
Daljnji autori: | Khair, Nishat Zareen |
Format: | Disertacija |
Jezik: | English |
Izdano: |
Brac University
2024
|
Teme: | |
Online pristup: | http://hdl.handle.net/10361/23842 |
Similar Items
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
od: Khan, Muidul Hasan
Izdano: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
od: Ruhee, Noshin Nawer
Izdano: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
od: Raju, Md. Ismail
Izdano: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
od: Ratu, Tabassum
Izdano: (2024)